who should not take glp-1 Drugs | Safety Guide GLP-1 Agonists, What Do I

Zepbound (tirzepatide) is an injectable prescription medicine approved for the treatment of obesity

Diabetes, Obesity and Metabolism, 20 (3), 610619

Consumers should verify current state eligibility directly with the platform, as telehealth regulations may change

This pathway also supports cell survival and proliferation, helping maintain sufficient cell mass to sustain normal insulin output

Status, Trials & Timeline (2026)

While individuals appear able to tolerate small increases in exercise relative to their normal routine, larger increases in training load are associated with higher heart rate and persistently lower HRV during GLP treatment[5]